Related Experiment Video
Updated: Mar 21, 2026
Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
Immunoexpression of Androgen Receptors in Poroid Neoplasms
Angel Fernandez-Flores1, David S Cassarino
1*Department of Cellular Pathology, Hospital El Bierzo, Ponferrada, Spain †Department of Pathology, Southern California Kaiser Permanente, Los Angeles Medical Center (LAMC), Kaiser Permanente, Los Angeles, CA.
Abstract:
Some poroid neoplasias are known to show apocrine differentiation (ie, differentiation toward the folliculosebaceous and the apocrine units). In this sense, it is somewhat surprising that the immunoexpression of androgen receptors (ARs) has not been investigated yet in poroid neoplasias. In this study, we examined the immunoexpression of ARs in 40 poroid neoplasms (8 porocarcinomas and 32 poromas). We found intense and diffuse immunoexpression of ARs in 1 porocarcinoma. In addition, 7 poromas and 2 porocarcinomas showed focal immunoexpression of ARs. Nine of these 10 positive cases were found in men. We conclude that poroid neoplasias express ARs in about 25% of the cases, but the expression is usually focal/weak. However, the expression of this marker is not incompatible with a diagnosis of poroid neoplasia.
